Beximco Pharmaceuticals Limited - GDR - Reg S BXP
LON: BXP | ISIN: US0885792061 30/04/2025
40,00 GBX (0,00%)
(0,00%)
30/04/2025
Profiel Beximco Pharmaceuticals Limited - GDR - Reg S
CEO: Nazmul Hassan